Product: Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505.  NDC: 0378-1300-01
Reason for recall: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: 20220126
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated